Life Sciences and healthcare focused private equity firm InvAscent has picked up a minority stake in Sunways India by investing Rs 120 crore ($15 million) from its India Life Sciences Fund III (ILSF III).

Sunways specialises in manufacturing and marketing of ophthalmology formulations.

Sunways will use the capital for capacity addition, international expansion and acquisitions.

Read more at:
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/invascent-picks-minority-stake-in-domestic-ophthalmic-formulation-firm-sunways-for-rs-120-crore/articleshow/95756461.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst